These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27933198)

  • 21. Significance of global versus segmental subclassification of class III and IV lupus nephritis: a single center experience.
    Nasri H; Baradaran A; Rafieian-kopaei M; Mubarak M
    Acta Reumatol Port; 2015; 40(2):138-44. PubMed ID: 25702048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions.
    Hiramatsu N; Kuroiwa T; Ikeuchi H; Maeshima A; Kaneko Y; Hiromura K; Ueki K; Nojima Y
    Rheumatology (Oxford); 2008 May; 47(5):702-7. PubMed ID: 18390590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in pathological pattern and treatment regimens based on repeat renal biopsy in lupus nephritis.
    Wang GB; Xu ZJ; Liu HF; Zhou QG; Zhou ZM; Jia N
    Chin Med J (Engl); 2012 Aug; 125(16):2890-4. PubMed ID: 22932086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy.
    Pagni F; Galimberti S; Galbiati E; Rebora P; Pietropaolo V; Pieruzzi F; Smith AJ; Ferrario F
    Nephrology (Carlton); 2016 Jan; 21(1):35-45. PubMed ID: 26132414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular expression of annexin A2 in lupus nephritis.
    Salle V; Cordonnier C; Schmidt J; Mazière C; Smail A; Attencourt C; Mabille MP; Mazière JC; Makdassi R; Choukroun G; Diouf M; Duhaut P; Ducroix JP
    J Clin Pathol; 2016 Jun; 69(6):533-6. PubMed ID: 26511441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal transplantation in lupus nephritis: a Brazilian cohort.
    Oliveira CS; d Oliveira I; Bacchiega AB; Klumb EM; Albuquerque EM; Souza E; Suassuna JH; Ribeiro FM
    Lupus; 2012 Apr; 21(5):570-4. PubMed ID: 22129601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of clinicopathologic correlations in Iranian patients with lupus nephritis.
    Shariati-Sarabi Z; Ranjbar A; Monzavi SM; Esmaily H; Farzadnia M; Zeraati AA
    Int J Rheum Dis; 2013 Dec; 16(6):731-8. PubMed ID: 24382282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial.
    Stoenoiu MS; Aydin S; Tektonidou M; Ravelingien I; le Guern V; Fiehn C; Remy P; Delahousse M; Petera P; Quémeneur T; Vasconcelos C; D'Cruz D; Gilboe IM; Jadoul M; Karras A; Depresseux G; Guillevin L; Cervera R; Cosyns JP; Houssiau FA;
    Nephrol Dial Transplant; 2012 May; 27(5):1924-30. PubMed ID: 22110048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon lambda modulates proinflammatory cytokines production in PBMCs from patients with chronic kidney disease.
    Xia Y; Yang Q; Wu SY; Wu Z; Li Q; Du J
    Hum Immunol; 2023 Sep; 84(9):464-470. PubMed ID: 37394297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis.
    Ding H; Kharboutli M; Saxena R; Wu T
    Clin Exp Immunol; 2016 Apr; 184(1):11-8. PubMed ID: 26616478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of repeat biopsy in lupus nephritis flares.
    Greloni G; Scolnik M; Marin J; Lancioni E; Quiroz C; Zacariaz J; De la Iglesia Niveyro P; Christiansen S; Pierangelo MA; Varela CF; Rosa-Diez GJ; Catoggio LJ; Soriano ER
    Lupus Sci Med; 2014; 1(1):e000004. PubMed ID: 25396056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like receptor 9 and vascular endothelial growth factor levels in human kidneys from lupus nephritis patients.
    Frieri M; Samih MA; Dzhindzhikhashvili M; Liu H; Balsam L; Rubinstein S
    J Nephrol; 2012; 25(6):1041-6. PubMed ID: 22344539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus.
    Ishizaki J; Saito K; Nawata M; Mizuno Y; Tokunaga M; Sawamukai N; Tamura M; Hirata S; Yamaoka K; Hasegawa H; Tanaka Y
    Rheumatology (Oxford); 2015 Mar; 54(3):405-12. PubMed ID: 25183834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of C1q deposition in serial biopsies for predicating the long-term outcome in patients with proliferative lupus nephritis.
    Alsuwaida A; Husain S; Al Ghonaim M; Aloudah N; Ullah A; Kfoury H
    Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):305-11. PubMed ID: 26997383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International survey on the management of patients with SLE. III. The results of a questionnaire regarding renal involvement.
    Doria A; Vitali C; Tincani A; Balestrieri G; Galeazzi M; Meroni PL; Migliorini P; Neri R; Tavoni A; Bombardieri S
    Clin Exp Rheumatol; 1996; 14 Suppl 16():S31-8. PubMed ID: 9049451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures.
    Wakasugi D; Gono T; Kawaguchi Y; Hara M; Koseki Y; Katsumata Y; Hanaoka M; Yamanaka H
    J Rheumatol; 2012 Jan; 39(1):79-85. PubMed ID: 22089455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18.
    Tucci M; Quatraro C; Lombardi L; Pellegrino C; Dammacco F; Silvestris F
    Arthritis Rheum; 2008 Jan; 58(1):251-62. PubMed ID: 18163476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP
    Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seasonal variation of lupus nephritis: high prevalence of class V lupus nephritis during the winter and spring.
    Schlesinger N; Schlesinger M; Seshan SV
    J Rheumatol; 2005 Jun; 32(6):1053-7. PubMed ID: 15940767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment.
    Kim YG; Kim HW; Cho YM; Oh JS; Nah SS; Lee CK; Yoo B
    Rheumatology (Oxford); 2008 Mar; 47(3):311-4. PubMed ID: 18204087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.